Warfarin potentiation: a review of the "FAB-4" significant drug interactions. (Record no. 18972601)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01098 a2200277 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250515175219.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200907s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0888-5109 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.4140/tcp.n.2009.227 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Thi, Linda |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20090715 |
| 245 00 - TITLE STATEMENT | |
| Title | Warfarin potentiation: a review of the "FAB-4" significant drug interactions. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists |
| Date of publication, distribution, etc. | Mar 2009 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 227-30 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Review |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Anticoagulants |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Interactions |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | International Normalized Ratio |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Warfarin |
| General subdivision | adverse effects |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shaw, David |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bird, Jennifer |
| 773 0# - HOST ITEM ENTRY | |
| Title | The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists |
| Related parts | vol. 24 |
| -- | no. 3 |
| -- | p. 227-30 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.4140/tcp.n.2009.227">https://doi.org/10.4140/tcp.n.2009.227</a> |
| Public note | Available from publisher's website |
No items available.